Serological Assessment for Leishmania donovani Infection in Blood Donors of Sunsari District, Dharan, Nepal

被引:0
作者
Suraj Timilsina
Narayan Raj Bhattarai
Basudha Khanal
Suman Rijal
机构
[1] Nepal Medical College,Department of Microbiology
[2] B.P. Koirala Institute of Health Sciences,Department of Microbiology
[3] B.P. Koirala Institute of Health Sciences,Department of Internal Medicine
来源
Indian Journal of Hematology and Blood Transfusion | 2016年 / 32卷
关键词
Asymptomatic blood donors; DAT; Dharan; Visceral leishmaniasis;
D O I
暂无
中图分类号
学科分类号
摘要
Visceral leishmaniasis (VL) is a major vector-borne disease caused by Leishmania donovani, after replication of the parasites in macrophages, mononuclear phagocytic system. VL is endemic in 12 districts of central and eastern Terai lowlands of Nepal bordering North Bihar, India with an estimated 8 million population at risk. In addition, VL endemicity is also extending to new endemic regions like Dharan from its classical rural foci. Hence, we aimed to detect the evidence of Leishmania donovani infection in the blood samples received from blood donors of Sunsari district, Dharan, (eastern Nepal), a region endemic for human VL. Sera from 507 asymptomatic blood donors were subjected to serological screening for anti-Leishmania donovani antibodies. Direct agglutination test (DAT) was performed on the sera. Out of 507 donors, majority (78.50 %) were male. Among the donors, 472 (93.10 %) belonged to age group 18–45 years where as 35 (6.90 %) to age group >45 years. Circulating anti-Leishmania antibodies were detected in 5 (1 %) out of 507 healthy, Human Immunodeficiency Virus types 1 and 2 (HIV 1and 2), Hepatitis B Surface Antigen (HBsAg), anti- Hepatitis C Virus (anti-HCV)-negative, and Syphillis non-reactive donors. All the seropositive cases were male and belonged to the age group 18–45 years. The result suggests that there is an immediate need of screening asymptomatic blood donors for leishmania seropositivity especially in endemic areas.
引用
收藏
页码:95 / 99
页数:4
相关论文
共 70 条
[1]  
Pearson RD(1995)Clinical spectrum of leishmaniasis Clin Infect Dis 22 1-13
[2]  
Sousa AQ(2001)Drug resistance in Indian visceral leishmaniasis Trop Med Int Health 6 849-854
[3]  
Sundar S(2010)Epidemiology of Leishmania donovani infection in high-transmission foci in Nepal Trop Med and Int Health 15 21-28
[4]  
Rijal S(2007)Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 5 873-882
[5]  
Uranw S(2003)USA blocks blood donation in bid to prevent leishmaniasis Lanc Infect Dis 3 746-1745
[6]  
Chappuis F(1995)Leish-KIT, a stable direct agglutination test based on freeze-dried antigen for serodiagnosis of visceral leishmaniasis J Clin Microbiol 33 1742-77
[7]  
Chappuis F(2004)A comparative study of the effectiveness of diagnostic tests for visceral leishmaniasis Am J Trop Med Hyg 70 72-836
[8]  
Sundar S(1994)Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis Am J Trop Med Hyg 51 826-396
[9]  
Hailu A(2011)Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control PLoS Negl Trop Dis 5 e1405-583
[10]  
Xavier B(2014)Strong association between serological status and probability of progression to clinical visceral leishmaniasis in prospective cohort studies in India and Nepal PLoS Negl Trop Dis 5 e1405-110